The Geelong Centre for Emerging Infectious Diseases (GCEID) is a collaborative, multidisciplinary research partnership between Deakin University, Barwon Health and CSIRO’s Australian Animal Health Laboratory (AAHL) based on a “One Health” approach to understanding and mitigating the risks posed by emerging infectious diseases.
Infectious diseases pose a direct hazard to human and animal health. Moreover, they threaten food security, through their effects on food producing livestock, and the environment, threatening wildlife and biodiversity. Most serious human infectious diseases are caused by zoonotic pathogens, which have their origins in wildlife and become increasingly infectious to both man and wildlife as a result of a range of global change processes.
Recent examples of zoonotic disease outbreaks highlight the devastating effects these agents can cause. Zoonotic microbial agents are also increasingly implicated in a number of other diseases, including allergies and cancer. Collectively, these emerging and zoonotic infectious diseases (EIDs) pose a clear threat to the health and economic prosperity of our and other nations. A holistic “One Health” approach, combining multidisciplinary expertise in human and animal health, biology, ecology, epidemiology and informatics, is required to effectively tackle this significant threat.
Combining these three entities into the Geelong Centre for Emerging Infectious Diseases (GCEID) will provide a One Health research centre that is nationally and globally unique and can serve to meet the current Victorian and broader national needs for EID research – essential for underpinning the EID policy and operational mitigation activities.
- Take an integrated ‘One Health’ approach to EIDs and focus on EID threats of national as well as Victorian significance
- Maximise the use of the human and physical resources amongst its partners, including the existing high containment facilities at CSIRO/AAHL
- Facilitate multi-disciplinary collaborations within GCEID
- Provide as a priority, research outcomes which have the potential for further development and commercialisation within the framework of BioGeelong